Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joel Trugman, MD
Forest Research Institute Inc., A Subsidiary of Forest Laboratories Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Forest Investigative Site 062
Birmingham, Alabama, United States
- Forest Investigative Site 065
Birmingham, Alabama, United States
- Forest Investigative Site 012
Tucson, Arizona, United States
- Forest Investigative Site 007
Fresno, California, United States
- Forest Investigative Site 032
Pismo Beach, California, United States
- Forest Investigative Site 025
Sacramento, California, United States
- Forest Investigative Site 019
San Diego, California, United States
- Forest Investigative Site 057
Santa Ana, California, United States
- Forest Investigative Site 039
Vista, California, United States
- Forest Investigative Site 050
Cromwell, Connecticut, United States
- Forest Investigative Site 049
Danbury, Connecticut, United States
- Forest Investigative Site 055
Stamford, Connecticut, United States
- Forest Investigative Site 011
Delray Beach, Florida, United States
- Forest Investigative Site 013
Ocala, Florida, United States
- Forest Investigative Site 016
Orlando, Florida, United States
- Forest Investigative Site 043
Palm Harbor, Florida, United States
- Forest Investigative Site 060
Pembroke Pines, Florida, United States
- Forest Investigative Site 009
Atlanta, Georgia, United States
- Forest Investigative Site 066
Atlanta, Georgia, United States
- Forest Investigative Site 026
Honolulu, Hawaii, United States
- Forest Investigative Site 056
Libertyville, Illinois, United States
- Forest Investigative Site 038
Peoria, Illinois, United States
- Forest Investigative Site 031
Evansville, Indiana, United States
- Forest Investigative Site 064
Frederick, Maryland, United States
- Forest Investigative Site 030
Newton, Massachusetts, United States
- Forest Investigative Site 048
North Dartmouth, Massachusetts, United States
- Forest Investigative Site 017
Springfield, Massachusetts, United States
- Forest Investigative Site 008
Worcester, Massachusetts, United States
- Forest Investigative Site 061
Kalamazoo, Michigan, United States
- Forest Investigative Site 020
Jackson, Mississippi, United States
- Forest Investigative Site 004
St Louis, Missouri, United States
- Forest Investigative Site 033
Cherry Hill, New Jersey, United States
- Forest Investigative Site 040
Albuquerque, New Mexico, United States
- Forest Investigative Site 035
Great Neck, New York, United States
- Forest Investigative Site 014
Rochester, New York, United States
- Forest Investigative Site 027
Syracuse, New York, United States
- Forest Investigative Site 054
Charlotte, North Carolina, United States
- Forest Investigative Site 018
Greensboro, North Carolina, United States
- Forest Investigative Site 002
Greenville, North Carolina, United States
- Forest Investigative Site 024
Salisbury, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 31 May 2010
- Completion
- —
- Last update posted
- 7 Sept 2011
- Registered enrollment
- 340
- Registry id
- NCT01014585
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.